loader

nasdaq:srne

LATEST ARTICLES
pharmaceutical investing

Sorrento Therapeutics Announces Merger of Scilex and Semnur

NASDAQ:SRNE

Sorrento Therapeutics Subsidiary Scilex Receives New Funding

pharmaceutical investing

Sorrento Therapeutics Subsidiary, Scilex, Raises $140 million in Non-Dilutive Royalty-Based Financing

pharmaceutical investing

1st Patient Treated for Osteoarthritis Knee Pain in Sorrento Resiniferatoxin Phase 1B Trial Meets Both Safety and Efficacy Expectations

pharmaceutical investing

Sorrento Acquires the Sofusa Lymphatic Delivery Platform for Immune-Oncology (I-O) Antibody Therapeutics

Latest News

More News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES